Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Pomegranate Health
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict61/ 100
Grade C · #316Pomegranate Health
Pomegranate Health sells compounded semaglutide and tirzepatide with no membership and no consultation fee.
Visit Pomegranate HealthThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 61/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Pomegranate Health still earns its place — shoppers who want a no-membership compounded GLP-1 whose semaglutide price is published on the product page itself.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results75
92
Real-world results75
97Price honesty28
97
Price honesty28
96Prescriber access57
96
Prescriber access57
88Formulary choice82
88
Formulary choice82
95Cancellation fairness56
95
Cancellation fairness56
93Member support74
93
Member support74
Price, coverage & features
| Metric | CoreAge Rx | Pomegranate Health |
|---|---|---|
| Verdict Score | 94/100 | 61/100 |
| Grade | A | C |
| Semaglutide | $149/mo | From $119/mo (starting price, compounded) |
| Tirzepatide | $349/mo | From $149/mo (Starter tier, compounded) |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Pomegranate Health
What we like
- No membership and no consultation fee — the site states 'No Membership required' and 'Transparent pricing, no hidden fees'
- The semaglutide price sits in the product page's own static HTML, so it can be read before any intake
- Shipping is included: 'shipped discreetly to your door at no extra cost'
- Both semaglutide and tirzepatide are offered
The caveats
- The tirzepatide price is not on the public site at all — it exists only inside the in-app pricing portal, and there is no standalone tirzepatide product page to read it from
- Both published figures are floors, a 'Starts @' and a Starter tier, and no price is published for the dose you titrate up to
- The states it can prescribe in are not disclosed anywhere; the dataset's own note records that semaglutide was unavailable in CA, IA and WI
- Klarna, Afterpay and Affirm are offered at checkout, so any monthly figure seen in a financing widget is an instalment and not the medication price
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Shoppers who want a no-membership compounded GLP-1 whose semaglutide price is published on the product page itself.
Visit Pomegranate Health Read the full Pomegranate Health review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programmes closest to it, and the same shortlist for Pomegranate Health does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.